ALEXANDRIA, Va. – In a federally funded, randomized phase III clinical trial performed by the Children’s Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free. These are the highest survival rates for these T-cell malignancies reported to date, according to the authors.
May 16, 2018
May 16, 2018
ALEXANDRIA, Va. – An analysis of 1,800 lung cancer screening sites nationwide found that only 1.9% of more than 7 million current and former heavy smokers were screened for lung cancer in 2016, despite United States Preventive Services Task Force (USPSTF) and ASCO screening recommendations. This study, the first assessment of lung cancer screening rates since those recommendations were issued in 2013, will be presented at the upcoming 2018 ASCO Annual Meeting in Chicago.
February 12, 2018
A new study suggests that a large percentage of adolescents and young adults (AYAs) who have been treated for cancer do not seek follow-up care after their primary treatment ends, despite its importance for long-term health. AYA cancer survivors are at increased risk for heart problems, infertility, and secondary cancers from cancer treatment.
ALEXANDRIA, Va. — At the 2023 ASCO Quality Care Symposium, ASCO will recognize Deborah K. Mayer, PhD, RN, AOCN, FAAN, with the Joseph Simone Quality Care Award and Lecture, which recognizes visionary oncology care providers who excel in quality care. Dr. Mayer will be the first nurse to receive this award. On Friday, October 27, 2023, at 10:45 AM ET, she will receive the award and present her lecture, “Reflections on Improving Cancer Care: How Can We Do Better for Our Patients and Ourselves?” The meeting will be held in Boston, MA, and online from October 27-28, 2023.
Pages |